Gene therapy and vein graft patency in coronary artery bypass graft surgery
- PMID: 16287962
- DOI: 10.1001/jama.294.19.2495
Gene therapy and vein graft patency in coronary artery bypass graft surgery
Comment in
-
Efficacy and safety of edifoligide.JAMA. 2006 Apr 5;295(13):1513-4; author reply 1514-5. doi: 10.1001/jama.295.13.1513-b. JAMA. 2006. PMID: 16595750 No abstract available.
Comment on
-
Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial.JAMA. 2005 Nov 16;294(19):2446-54. doi: 10.1001/jama.294.19.2446. JAMA. 2005. PMID: 16287955 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical